Search Results for: BSX
Generally speaking, we do not like to bring CEOs back from a past "list of CEOs to go." James Tobin of Boston Scientific Corp. (NYSE: BSX) has somehow managed to hang on to his job...
Published:
Last Updated:
Many research firms have been coming up with their best ideas lists for 2012. Today brought a list of top picks in the medical technology and medical devices sector from Zacks Investment...
Published:
Last Updated:
Medical device maker Boston Scientific Corp. (NYSE: BSX) has named a new president who will take over on October 17th and who will then be elevated to CEO on November 1, 2012. Was Boston...
Published:
Last Updated:
2007 has been a volatile year in the stock market, but there are many key technology CEO’s who just aren’t making a passing grade. 247WallSt.com has issued a brief list of some recognized...
Published:
Last Updated:
Abbott Labs (ABT) which just launched a new stent product, Xience V, has laid off 1,200 people because of slowness in the stent market. Stranger than fiction. According to MarketWatch, Abbott says it...
Published:
Several studies which showed that stents could cause blood clotting in the heart have done significant damage to the revenue for those products at Boston Scientific (BSX) and Johnson & Johnson...
Published:
Medtronic, Inc. (NYSE: MDT) has just announced that it has received formal approval from the FDA to market its Endeavor Zotarolimus-Eluting Coronary Stent System for the treatment of coronary artery...
Published:
Boston Scientific Corporation (NYSE: BSX) has been a long and painful investment for thousands of shareholders who have held shares in hopes that this turnaround stock can eventually turn around. ...
Published:
Abbot Labs (ABT) is trying to get into the stent business. The market has been dominated by Boston Scientific (BSX) and Johnson & Johnson (JNJ). Stents are small mess implants which are designed...
Published:
There will start to become an obvious here in our after-hours movers… Earnings reports. That is not the entire case tonight, although earnings are impacting shares. Tonight’s after-hours move...
Published:
Last Updated:
Wall St. has gone from hating financial firms with bad balance sheets to hating all companies with big pools of debt. With the crisis which has evolved over the last few day, debtophobia has gotten...
Published:
It seems that all of a sudden corporations are deciding to do the right thing by getting rid CEO’s that have put the companies and shareholders in untenable positions. We called CEO James...
Published:
Last Updated:
It is always interesting seeing which groups and which stocks saw the biggest changes in short interest. This list doesn’t show financials because we’ve already shown that...
Published:
Last Updated:
James Tobin, the CEO of Boston Scientific (NYSE:BSX) is likely to find himself in front of the shareholder firing squad in 2008. In early 2004 this stock was above $40 and had enjoyed an...
Published:
Last Updated:
These are some of the top pre-market analyst upgrades and positive research calls we have seen from Wall Street early this Friday morning with more than two hours until the market opens: ARM Holdings...
Published: